Vivanza Biosciences Market Cap

Vivanza Biosciences has a market cap or net worth of 80.80 million as of March 10, 2026. Its market cap has decreased by -16.87% in one year.

Market Cap

80.80M

Enterprise Value

176.11M

Revenue

1.10B

Ranking

n/a

PE Ratio

n/a

Stock Price

2.02

Market Cap Chart

Since October 23, 2012, Vivanza Biosciences's market cap has decreased from 178.64M to 80.80M, a decrease of -54.77%. That is a compound annual growth rate of -5.76%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	77.20M	-12.27%
Dec 31, 2025	88.00M	-35.67%
Dec 31, 2024	136.80M	-68.25%
Dec 29, 2023	430.80M	-30.96%
Dec 23, 2022	624.00M	-12.92%
Dec 27, 2021	716.60M	59.67%
Dec 31, 2020	Pro	Pro
Dec 24, 2019	Pro	Pro
Dec 13, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ganga Pharmaceuticals	70.94M
Unjha Formulations	90.95M
Beryl Drugs	94.44M
Decipher Labs	62.62M
Brawn Biotech	60.82M
Colinz Laboratories	105.42M
Shamrock Industrial Company	110.51M
Emmessar Biotech & Nutrition	123.90M

Market Cap Rankings